Amit Munshi, ReNAgade Therapeutics CEO

Amit Mun­shi has more than $300M and a start­up CSO out to pi­o­neer next-gen RNA ther­a­peu­tics. Once again, he’s think­ing big

Amit Mun­shi had to beg off when he was first in­tro­duced to the idea of run­ning an MPM BioIm­pact stealth play­er named Re­NA­gade Ther­a­peu­tics. He …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.